Can a 3-Step exercise plan become standard in cancer care?
NCT ID NCT07210905
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a simple 3-step exercise protocol (assess, advise, refer) can be made a standard part of cancer care. Researchers will train clinic staff and track how many eligible patients are screened and referred to a weight management program. About 1,800 cancer survivors who finished treatment within the past five years will take part.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
3-step Assess-Advise-Refer exercise protocol (FitARise)
What this could lead to
If successful, this could make exercise counseling a routine part of cancer care, helping more patients get support to improve their health after treatment.
What could go wrong
This is an implementation study, not a test of a new drug or treatment. It focuses on changing how clinics work, so even if it succeeds, direct patient benefits may take time and may not be seen in all settings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
KWH Department of Surgery
Hong Kong, Hong Kong
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
PMH Department of Oncology
Hong Kong, Hong Kong
Contact
Contact Email: •••••@•••••
-
PYEH Department of Clinical Oncology
Hong Kong, Hong Kong
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
QMH Department of Clinical Oncology
Hong Kong, Hong Kong
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
QMH Department of Obstetrics and Gynaecology
Hong Kong, Hong Kong
Contact Email: •••••@•••••
-
QMH Department of Surgery
Hong Kong, Hong Kong
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
TMH Department of clinical oncology
Hong Kong, Hong Kong
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
YCH Surgery Department
Hong Kong, Hong Kong
Contact Phone: •••-•••-•••• Email: •••••@•••••